Evolving Landscape of Sickle Cell Anemia Management in Africa: A Critical Review
- PMID: 39728819
- PMCID: PMC11680351
- DOI: 10.3390/tropicalmed9120292
Evolving Landscape of Sickle Cell Anemia Management in Africa: A Critical Review
Abstract
Sickle cell disease (SCD) is a prevalent inherited blood disorder, particularly affecting populations in Africa. This review examined the disease's burden, its diverse clinical presentations, and the challenges associated with its management in African settings. Africa bears a significant burden of SCD, with prevalence varying across countries and age groups. Newborn screening programs have highlighted the high prevalence of SCD at birth, emphasizing the need for early diagnosis and intervention. The clinical manifestations of SCD in Africa are multifaceted, encompassing acute complications like vaso-occlusive crises, acute chest syndrome, and stroke, as well as chronic complications such as organ damage and leg ulcers. Biological factors, including fetal hemoglobin levels, and demographic factors, like age and sex, influence disease severity and outcomes. The management of SCD in Africa faces numerous challenges. Limited access to resources, including diagnostic tools, medications, and trained healthcare professionals, hinders optimal care. The high cost of advanced therapies further restricts patient access. Cultural stigma and a lack of awareness create additional barriers to effective management. To address these challenges, early diagnosis through newborn screening programs and point-of-care testing is crucial. Comprehensive care models, including hydroxyurea therapy, pain management, and patient education, are essential for improving outcomes. Collaboration with international networks and leveraging local resources can enhance the sustainability of SCD programs. In conclusion, SCD significantly impacts African populations. Overcoming the challenges associated with its management requires addressing resource limitations, affordability issues, and cultural barriers. Early diagnosis, comprehensive care models, and ongoing research focused on affordability and accessibility are crucial for improving the lives of individuals living with SCD in Africa.
Keywords: Africa; disease management; sickle cell disease.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Caring for Africa's sickle cell children: will we rise to the challenge?BMC Med. 2020 Apr 28;18(1):92. doi: 10.1186/s12916-020-01557-2. BMC Med. 2020. PMID: 32340612 Free PMC article.
-
A Retrospective Analysis of Demographics, Clinical Features, and Treatment Patterns in Sickle Cell Disease Patients at a Tertiary Healthcare Centre of North East India.Cureus. 2024 Nov 26;16(11):e74489. doi: 10.7759/cureus.74489. eCollection 2024 Nov. Cureus. 2024. PMID: 39726467 Free PMC article.
-
Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.Pharmacotherapy. 2023 May;43(5):430-441. doi: 10.1002/phar.2792. Epub 2023 Mar 26. Pharmacotherapy. 2023. PMID: 36906823 Review.
-
Sickle Cell Disease: A Review.JAMA. 2022 Jul 5;328(1):57-68. doi: 10.1001/jama.2022.10233. JAMA. 2022. PMID: 35788790 Review.
-
Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.MMWR Surveill Summ. 2022 Oct 7;71(9):1-18. doi: 10.15585/mmwr.ss7109a1. MMWR Surveill Summ. 2022. PMID: 36201430 Free PMC article.
References
-
- Williams T.N. Sickle Cell Disease in Sub-Saharan Africa. Routledge; London, UK: 2024. The Clinical Epidemiology of Sickle Cell Disease in Sub-Saharan Africa; pp. 4–31.
-
- Ojelabi A. Public Health in Sub-Saharan Africa: Social Epidemiological Perspectives. Taylor & Francis; Oxfordshire, UK: 2024. Sickle Cell Disease in Africa; p. 140.
-
- WHO. World Health Organization Sickle Cell Disease. 2021. [(accessed on 1 September 2024)]. Available online: https://www.afro.who.int/health-topics/sickle-cell-disease.
Publication types
LinkOut - more resources
Full Text Sources